Investopedia writers come from a wide variety of financial backgrounds. While we encourage all authors to provide their bios we do not list the backgrounds of certain authors because we believe this anonymity allows the author to provide his or her viewpoint unencumbered by the perceptions of others.

If your investing prowess and passion for finance is matched only by your exceptional writing abilities, we'd like to meet you. Apply now to become a writer for Investopedia and help educate the world about finance.

  • Showing 1-15 of 6,807 items
  • 1
  • 2
  • 3
  • ...
  • 454
  • >>
  1. Stock Analysis

    3 Stocks To Buy and Hold For the Rest of 2015

    One of the dominant themes to consider for 2015 is the normalization of monetary policy as the Fed raises interest rates.
  2. Stock Analysis

    Rite Aid's 5 Key Strategies for Long-Term Success

    Drugstore-chain Rite Aid (NYSE: RAD) has turned itself around impressively, having spent a huge amount of time and effort in returning to profitability. The company has used a combination of strategies ...
  3. Stock Analysis

    3 Reasons ARM Holdings' Stock Could Rise

    Shares of semiconductor specialist ARM Holdings (NASDAQ: ARMH) have more than quadrupled in value over the past five years as strong demand for smartphones has driven the company's revenue and profits ...
  4. Stock Analysis

    2 Major Product Launches for Intel This Year

    The second half of 2015 will be a busy one for chip giant Intel (NASDAQ: INTC). The company has two major product launches slated for the second half of this year, and both have important implications ...
  5. Stock Analysis

    3 Reasons Altria Group Stock Could Fall

    For long-term investors, Altria Group (NYSE: MO) has been one of the most resilient stocks in the market, defying lawsuits and regulatory attempts to hamstring its tobacco business for years. Yet despite ...
  6. Stock Analysis

    3 Reasons Johnson & Johnson Stock Could Rise

    There are few companies these days that can truly be classified as "safe" investments, but I'd opine that healthcare conglomerate Johnson & Johnson (NYSE: JNJ) is among the elite class of companies ...
  7. Stock Analysis

    The Big News at Annaly Capital Management

    Last month, Annaly Capital Management (NYSE: NLY) issued a press release that, if you weren't paying close attention, could easily have seemed like nothing out of the ordinary. In reality, however, the ...
  8. Stock Analysis

    Is United Airlines About to Expand in Brazil?

    On Friday, United Continental (NYSE: UAL) announced it had reached an agreement with No. 3 Brazilian carrier Azul on a long-term strategic partnership. As part of the arrangement, United is making a $1 ...
  9. Stock Analysis

    Is Emerge Energy Services Stock a Buy?

    Ever since Emerge Energy Services' (NYSE: EMES) IPO back in 2013, its shares have been on a journey that looks an awful lot like the flight of Icarus. The company's business, which held so much promise, ...
  10. Stock Analysis

    Why Marvin Ellison Is an Ideal CEO for J.C. Penney

    J.C. Penney (NYSE: JCP) has made its fair share of mistakes over the past five years -- particularly during former-CEO Ron Johnson's short but infamous tenure from 2011-2012 -- but hiring Marvin Ellison ...
  11. Stock Analysis

    3 Reasons Zillow Group Stock Could Rise

    Shares of Zillow Group (NASDAQ: Z) have fallen more than 20% over the past month, hurt by the release of the online real estate specialist's mixed first-quarter results in May. But that doesn't mean Zillow ...
  12. Stock Analysis

    3 Key Numbers for Nuance Communications Investors

    Nuance Communications (NASDAQ: NUAN), a provider of voice and language software, has seen its stock rise nearly 25% so far this year. The company's technology powers Apple's Siri, and with speech-recognition ...
  13. Stock Analysis

    Analysts Battle Over MannKind -- but Who's Right?

    Source: YCharts. The past two months have brought about some very turbulent times for MannKind (NASDAQ: MNKD) shareholders. It all began in May, with negative commentary from two Wall Street companies. ...
  14. Stock Analysis

    5 Things Cognex's Management Wants You to Know

    As Cognex (NASDAQ: CGNX) CEO Rob Willet noted in the company's first-quarter earnings release: "..revenue, net income, and earnings per share all set new first quarter records, as a result of our ongoing ...
  15. Stock Analysis

    3 Reasons Why Opko Health's Stock Could Soar

    Opko Health's (NYSE: OPK) CEO Phillip Frost has a proven track-record of building and growing successful biopharma companies, and his serial deal-making approach has saddled Opko Health with a stable ...
  • Showing 1-15 of 6,807 items
  • 1
  • 2
  • 3
  • ...
  • 454
  • >>

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!